Synthetic Hemostatic and Wound Care Products Market Key Highlights:
- Market Size (2024): USD 4,606 Million
- Projected Market Size (2034): USD 8,018 Million
- CAGR (2024-2034): 5.7%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
Synthetic Hemostatic and Wound Care Products Market Definition
With a significant increase in the incidence of accident injuries, the demand for synthetic hemostatic and wound care products has increased in the past few years. For instance, according to the World Health Organization (WHO), road traffic injuries take the lives of about 1.19 million people around the world each year. However, synthetic hemostatics are medicines administered to reduce bleeding from a ruptured blood vessel, as accessive bleeding makes it impossible for the heart to pump sufficient blood through the body.
It is projected that the growing geriatric population, coupled with the increasing prevalence of chronic diseases, will contribute to the growth of the synthetic hemostatic and wound care products market. Older people are more prone to chronic diseases, and so are chronic wounds, requiring wound care products. Moreover, the increasing number of surgical procedures further boosts the market. However, advancements in healthcare technology led to the emergence of minimally invasive surgeries, which reduce bleeding and thus the need for hemostatics.
Market players are developing innovative products to hold a large market share and stay ahead of the competition. For instance, in November 2023, Ethicon, a subsidiary of Johnson & Johnson, launched ETHIZIA Hemostatic Sealing Patch, which is clinically proven to stop disruptive bleeding.
Synthetic Hemostatic and Wound Care Products Market Segmentation:
By Type
- Disposable Products
- Multi-use Products
By Application
- Hospital
- Clinic
- Pharmacy
- Other
Synthetic Hemostatic and Wound Care Products Market Companies:
- Johnson & Johnson (Ethicon)
- Baxter International
- B. Braun Melsungen AG
- CryoLife
- Medtronic
- Integra LifeSciences
- Pfizer
- Z-Medica LLC
- Teleflex Medical
- HemCon Medical Technologies
- W.L. Gore & Associates
- Mölnlycke Health Care
- Systagenix
- Smith & Nephew
- HemaClear
- QuikClot (Z-Medica)
- Surgical Specialties Corporation
- Stryker Corporation
- CuraMedical
- Acelity (KCI)
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
